- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06567236
E4D Compare Adapted to Preclinical Endodontics
August 21, 2024 updated by: Texas A&M University
E4D Compare Adapted to Evaluate Pulpal Access Cavity Preparation in the D2 Preclinical Endodontics Course: Educational Randomized Controlled Trial
Based on pilot study's promising results, we decided to further investigate the impact of adapting Planmeca Romexis Compare software to evaluate pulpal access preparations on second-year dental students' technical performance, self-evaluation skills and opinions.
No educational records, grades, coursework, or any other assignments that are completed as part of the regular class will be analyzed as part of this study.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
59
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Second-year dental students enrolled in DDDS 719 Integrated Practice of Dentistry Lab II during 2022-2023 at Texas A&M School of Dentistry
- Students who have completed fixed prosthodontics preclinical course
- Students attending the endodontics preclinical course.
Exclusion Criteria:
- First, third and fourth-year dental students at Texas A&M School of Dentistry
- Second-year dental students NOT enrolled in DDDS 719 Integrated Practice of Dentistry Lab II during 2022-2023 at Texas A&M School of Dentistry
- Students who are not interested in participating.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-assessment - traditional method vs traditional method plus 3D software method
Time Frame: baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
|
Compare self-assessment after traditional method only and with extra 3D software method
|
baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
|
|
Grading - traditional method vs traditional method plus 3D software method
Time Frame: baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
|
Compare technical skills after traditional method only and with extra 3D software method
|
baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Grading - traditional/visual grading vs 3D software grading
Time Frame: baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
|
Compare traditional/visual grading to 3D software grading using different tolerance levels
|
baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 27, 2023
Primary Completion (Actual)
May 8, 2023
Study Completion (Actual)
May 8, 2023
Study Registration Dates
First Submitted
August 19, 2024
First Submitted That Met QC Criteria
August 21, 2024
First Posted (Actual)
August 22, 2024
Study Record Updates
Last Update Posted (Actual)
August 22, 2024
Last Update Submitted That Met QC Criteria
August 21, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- IRB2022-1492-CD-EXM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Self-Perception
-
University of ZurichTerminatedVerticality Perception | Self-motion PerceptionSwitzerland
-
University of BarcelonaUniversitat Autonoma de Barcelona; European UnionRecruitingSelf-Perception | Self Esteem | SelfSpain
-
Kolding SygehusCompleted
-
Lebanese UniversityCompleted
-
Centre Hospitalier Universitaire de Saint EtienneUniversity of LyonRecruiting
-
Centre Hospitalier Universitaire de Saint EtienneUniversity of LyonRecruitingSelf-PerceptionFrance
-
Johannes Kepler University of LinzMedical University of Graz; FH Joanneum Gesellschaft mbH; Kepler University HospitalNot yet recruitingPerception, Self | Self-Assessment | Body Awareness
-
Johannes Kepler University of LinzMedical University of GrazCompleted
-
Johannes Kepler University of LinzMedical University of GrazCompleted
-
Acibadem UniversityCompleted